UK adverse event reporting
This article was originally published in The Tan Sheet
Consumers, parents and care providers now are able to report adverse drug reactions under a new pilot scheme launched by the UK's Medicines & Healthcare products Regulatory Agency Jan. 17. Previously the country's "Yellow Card" reporting scheme only allowed healthcare professionals to report drug-related adverse events, the health agency notes. The new system "will help the MHRA better understand the patient's experience and perspective of suspected adverse drug reactions." Patients can submit their reports online or on paper-based report forms...
You may also be interested in...
Senior executives from Bayer outlined at a recent summit the contours of digital transformation already underway and the vital components of a successful digital team. Firms need to be able to operate technology at the “speed of business” and not “at the speed of a ticketing queue.”
A Senate Health Committee update hearing on the COVID-19 federal response was noteworthy primarily for demonstrating that FDA Commissioner Stephen Hahn appears to have salvaged the agency’s position as a voice of credibility with a key political constituency – at least for now.
The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.